Gregory Lawrence
Geen lopende functies
Profiel
Gregory Lawrence worked as a Lead Researcher at Polymer Technology Systems, Inc., Vice President-Research & Development at Verax Biomedical, Inc., and Head-Research & Development at Quadraspec, Inc.
Eerdere bekende functies van Gregory Lawrence
Bedrijven | Functie | Einde |
---|---|---|
Quadraspec, Inc.
Quadraspec, Inc. Medical SpecialtiesHealth Technology Quadraspec, Inc. is a diagnostic company engaged in the development of in-vitro diagnostic products for the laboratory, clinical, research and life sciences markets. Their products are used in veterinary for canine heartworm, by biotechnology companies for assay development, biomarker identification, and patient screening during pre-clinical and clinical development and in clinical diagnostics. It developed a direct detection technology which eliminates the usage of secondary and labeled reagents. The company’s proprietary Spinning Disc Interferometry (SDI) Detection technology platform detects and quantifies more than 1,000 unique antigens, biomarkers, or other molecular species on a single array providing a reagent-free detection technology. Its dual channel detector, Inspira Reader features reagent-free detection and orthogonal detection method for quantification of molecular assays. The company was founded in 2004 and is headquartered in West Lafayette, Indiana. | Hoofd Techniek/Wetenschap/O&O | - |
Polymer Technology Systems, Inc.
Polymer Technology Systems, Inc. Medical SpecialtiesHealth Technology Polymer Technology Systems, Inc. develops, manufactures and sells hand-held diagnostic devices. It is an point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. The company was founded in 1992 and is headquartered in Indianapolis, IN. | Corporate Officer/Principal | - |
Verax Biomedical, Inc.
Verax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA. | Hoofd Techniek/Wetenschap/O&O | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Verax Biomedical, Inc.
Verax Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services Verax Biomedical, Inc. develops rapid tests for detecting bacterial contaminants in blood cells and tissues. The firm's first target application for its technology is to test for the presence of bacterial contaminants in platelets and bacterial contaminants in platelets and red blood cells represent the greatest lethal infectious risks in transfusion medicine today and no rapid, simple methods are presently available to effectively address this threat. Verax Biomedical was founded by Joe R. Sanders and Joe L. Straight in 1999 and is headquartered in Marlborough, MA. | Commercial Services |
Quadraspec, Inc.
Quadraspec, Inc. Medical SpecialtiesHealth Technology Quadraspec, Inc. is a diagnostic company engaged in the development of in-vitro diagnostic products for the laboratory, clinical, research and life sciences markets. Their products are used in veterinary for canine heartworm, by biotechnology companies for assay development, biomarker identification, and patient screening during pre-clinical and clinical development and in clinical diagnostics. It developed a direct detection technology which eliminates the usage of secondary and labeled reagents. The company’s proprietary Spinning Disc Interferometry (SDI) Detection technology platform detects and quantifies more than 1,000 unique antigens, biomarkers, or other molecular species on a single array providing a reagent-free detection technology. Its dual channel detector, Inspira Reader features reagent-free detection and orthogonal detection method for quantification of molecular assays. The company was founded in 2004 and is headquartered in West Lafayette, Indiana. | Health Technology |
Polymer Technology Systems, Inc.
Polymer Technology Systems, Inc. Medical SpecialtiesHealth Technology Polymer Technology Systems, Inc. develops, manufactures and sells hand-held diagnostic devices. It is an point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. The company was founded in 1992 and is headquartered in Indianapolis, IN. | Health Technology |